Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 19018 [2012-7551]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
19018
Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines, which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
most recently, August 3, 2011, and will
expire on August 3, 2013.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the conference call includes: SEC Petition for
Feed Materials Production Center (Fernald,
Ohio); Subcommittee and Work Group
Updates; SEC Petition Evaluations Update for
the June 2012 Advisory Board Meeting; and
Board Correspondence.
The agenda is subject to change as
priorities dictate.
Because there is not a verbal public
comment period, written comments may be
submitted. Any written comments received
will be included in the official record of the
meeting and should be submitted to the
contact person below in advance of the
meeting.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600 Clifton
Road NE., Mailstop: E–20, Atlanta, Georgia
30333, Telephone (513)533–6800, Toll Free
1(800) CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Mar<15>2010
17:14 Mar 28, 2012
Jkt 226001
Dated: March 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Dated: March 23, 2012.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2012–7554 Filed 3–28–12; 8:45 am]
[FR Doc. 2012–7551 Filed 3–28–12; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned committee.
The meeting announced below
concerns Conducting Public Health
Research in South Africa, Funding
Opportunity Announcement (FOA)
GH12–004, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8:30 a.m.–3 p.m. (EDT),
April 26, 2012.
Place: CDC, 1600 Clifton Road NE.,
Building 21, Rooms 1204 A/B, Atlanta,
Georgia 30333. This meeting is also available
by teleconference. Please dial (877) 930–8819
and enter code 1579739.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
period. The public comment period is
tentatively scheduled from 2:45 p.m. until
2:50 p.m.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters To Be Discussed: The Advisory
Committee to the Director will receive
updates from the Global Workgroup; State,
Tribal, Local and Territorial Workgroup; the
Policy Workgroup; the Communications
Workgroup; the Ethics Subcommittee, and
the Health Disparities Subcommittee, as well
as an update from the CDC Director.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, Advisory Committee to the Director,
CDC, 1600 Clifton Road NE., M/S D–14,
Atlanta, Georgia 30333, telephone 404/639–
7000, email: GHickman@cdc.gov. The
deadline for notification of attendance is
April 20, 2012. To register for this meeting,
please send an email to ACDirector@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00022
Fmt 4703
Sfmt 9990
Time and Date: 12 p.m.–4 p.m., May 2,
2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Conducting Public Health
Research in South Africa, FOA GH12–004.’’
Contact Person for More Information: Lata
Kumar, Scientific Review Officer, CGH
Science Office, Center for Global Health,
CDC, 1600 Clifton Road NE., Mailstop D–69,
Atlanta, Georgia 30033, Telephone (404)
639–7618.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–7545 Filed 3–28–12; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 77, Number 61 (Thursday, March 29, 2012)]
[Notices]
[Page 19018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7551]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC announces the following meeting
of the aforementioned committee.
Time and Date: 8:30 a.m.-3 p.m. (EDT), April 26, 2012.
Place: CDC, 1600 Clifton Road NE., Building 21, Rooms 1204 A/B,
Atlanta, Georgia 30333. This meeting is also available by
teleconference. Please dial (877) 930-8819 and enter code 1579739.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment period. The public comment
period is tentatively scheduled from 2:45 p.m. until 2:50 p.m.
Purpose: The committee will provide advice to the CDC Director
on strategic and other broad issues facing CDC.
Matters To Be Discussed: The Advisory Committee to the Director
will receive updates from the Global Workgroup; State, Tribal, Local
and Territorial Workgroup; the Policy Workgroup; the Communications
Workgroup; the Ethics Subcommittee, and the Health Disparities
Subcommittee, as well as an update from the CDC Director.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Carmen Villar, MSW,
Designated Federal Officer, Advisory Committee to the Director, CDC,
1600 Clifton Road NE., M/S D-14, Atlanta, Georgia 30333, telephone
404/639-7000, email: GHickman@cdc.gov. The deadline for notification
of attendance is April 20, 2012. To register for this meeting,
please send an email to ACDirector@cdc.gov. The Director, Management
Analysis and Services Office, has been delegated the authority to
sign Federal Register notices pertaining to announcements of
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 23, 2012.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2012-7551 Filed 3-28-12; 8:45 am]
BILLING CODE 4163-18-P
